glp-1 oral weight loss Scam weight-loss drops marketed to Australians contain 'basically salty water', analysis finds | Scams 3 Takeaways from the Landmark
Description
The SURMOUNT-1 trial evaluating tirzepatide demonstrated substantial results, with participants achieving mean weight reductions of approximately 15% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) over 72 weeks
LegitScript certified, month-to-month billing
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Di Tomo P, Lanuti P, Di Pietro N, Baldassarre MPA, Marchisio M, Pandolfi A, et al
LC revised the manuscript
Measure both flaccid and erect length under similar conditions each time
